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ABSTRACT: Many mutations and allelic variants are known
that inﬂuence the rate at which animals age, but when in life do
such variants diverge from normal patterns of aging? Is this
divergence visible in their physiologies? To investigate these
questions, we have used 1H NMR spectroscopy to study how
the metabolome of the nematode Caenorhabditis elegans
changes as it grows older. We identify a series of metabolic
changes that, collectively, predict the age of wild-type worms.
We then show that long-lived mutant daf-2(m41) worms are
metabolically youthful compared to wild-type worms, but that
this relative youth only appears in middle age. Finally, we show
that metabolic age predicts the timing and magnitude of diﬀerences in age-speciﬁc mortality between these strains. Thus, the
future mortality of these two genotypes can be predicted long before most of the worms die.
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■ INTRODUCTION
Is it possible to predict the length of life remaining for any one
individual? Some have suggested so;1 however, there are
substantial technical impediments. However, it is not unrealistic
to predict the probable lifespan remaining at diﬀerent points in
lifethe basis of the actuarial industry. Can this statistical
approach be informed by the biological signature of an
organismcan it increase the precision of these estimates?
There are two obvious sources of information which might do
so: personalized genomic data and phenotypic data, and it is
likely that they will be especially powerful in combination.
Here, we investigate this possibility by combining genetic with
metabolic phenotypic data.
The untargeted proﬁling of small-molecule metabolites
(metabolomics) gives an alternative measure of biochemical
phenotype. This gives arguably the most direct phenotypic
measurement at a cellular level: it integrates the complex
upstream eﬀects of regulation at transcriptional, translational,
and post-translational levels.2 In addition, and unlike genomic
proﬁling, metabolomics is able to report on the combined
eﬀects of both genotype and environment (e.g., diﬀerent
dietary choices); this forms the basis of the so-called
“pharmacometabonomic” or “pharmacometabolomic” ap-
proach, in which metabolic proﬁles are used to predict the
response to drugs, integrating both genetic and environmental
factors.3−5
Caenorhabditis elegans has a relatively short lifespan of around
2−3 weeks (depending on temperature and food availability),
which makes it an ideal model for the study of aging.
Additionally, many single gene mutations have been found to
increase the lifespan of C. elegans. Many of these genes are
components of the insulin/IGF-1-like signaling pathway and act
via the transcription factor DAF-16 to activate genes associated
with protection against oxidative stress and heat shock, those
linked with autophagy and innate immunity, as well as other
genes associated with survival.6 The daf-2 gene is an orthologue
of the human insulin receptor gene and is essential in C. elegans.
However, certain hypomorphic mutations of daf-2 increase
lifespan; the amount of lifespan extension is variable between
diﬀerent mutants and depends on the environment, but daf-2
lifespan can be as much as double that of wild-type.7,8
As a phenomenon, aging clearly has many metabolic
components. Longevity pathways are associated with speciﬁc
metabolic enzymes, with many metabolism-linked genes
activated by DAF-16.9−11 Wild-type worms have an abundance
of proteins involved with lipid transport and translation
elongation greater than that of daf-2 worms, while these
mutants have a comparatively high abundance of proteins
involved in the biosynthesis of amino acids and the metabolism
of reactive oxygen species, as well as those involved with
carbohydrate metabolism.12 Longevity-associated pathways
have also been linked with key regulators of metabolism in C.
elegans. The ratio of AMP to ATP is a measure of energy
availability, and this ratio increases with age and changes in
response to environmental stress. In worms, the AMP-activated
protein kinase subunit AAK-2 acts as a sensor, being activated
by AMP. Both environmental stress and reduced insulin
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signaling have been found to increase longevity via AAK-2,
which acts in parallel to DAF-16 to control lifespan.13 In
addition to this, long-lived dauer larvae are known to have
altered metabolism, as reviewed by Braeckman et al.,14 with a
decreased metabolic rate and a reliance on lipids as a primary
energy reserve rather than the combination of lipid and
carbohydrate metabolism observed in non-dauer worms.
Given this, it is not surprising that recent studies have used
metabolomic proﬁling to directly study the phenotypic changes
that occur during aging.15−19 Previous metabolomic studies
with C. elegans have focused on mutant comparisons rather than
the aging process per se.20−24 We have previously analyzed
metabolic changes during development;25 here, we have used
nuclear magnetic resonance (NMR) spectroscopy in an
untargeted analysis of the metabolic changes that take place
during the aging process, both in the wild-type and in a long-
lived IIS mutant strain, and compared these to the mortality
rate observed at diﬀerent points in the life cycle.
■ MATERIALS AND METHODS
C. elegans Strains and Cultivation
We obtained worm strains (wild-type N2 and daf-2(m41))
from the Caenorhabditis Genetics Center (CGC). We
maintained them at 20 °C on Escherichia coli OP50 on
nematode growth medium (NGM (17 g L−1 agar, 3 g of NaCl,
2.5 g of peptone, 1 mM CaCl2, 1 mM MgSO4, 25 mM K2HPO4
(pH 6), 0.1% cholesterol)). For the metabolite analysis, we
synchronized the worms by hypochlorite treatment: bleaching
solution (20% NaOCl (4%), 5% 10 M NaOH) was added to a
pellet of gravid adults. After shaking and centrifugation, the
pellet was washed with M9 buﬀer (22 mM KH2PO4, 42 mM
Na2HPO4, 85.5 mM NaCl, 1 mM MgSO4) and then transferred
to a fresh NGM. When the worms reached young adulthood
(deﬁned as the point where there were eggs seen on the plates
but no second-generation worms had hatched), they were
transferred to plates containing 100 mg L−1 ﬂuorodeoxyuridine,
in order to inhibit the growth of oﬀspring so that all samples
came from age-synchronous populations. We sampled them at
young adulthood (60 h posthatch (p.h.) for N2 and 80 h p.h.
for daf-2(m41)) and then at 6, 8, 10, 13, 16, and 20 days p.h.
After 10 days, the worms were moved to fresh plates, and food
(E. coli OP50 culture) was added regularly. We combined the
worms from three individual 9 cm agar plates to make a single
replicate (n = from 3 to 6). We sampled the worms by washing
the plates in M9 buﬀer, allowing them to settle for 3 min, and
aspirating oﬀ the supernatant. The pellets were snap-frozen and
stored until metabolite analysis.
Survival Analysis
Worms were grown up following the protocol above, except
that from young adulthood, they were kept 20 individuals per
plate; we then monitored their survival until death (total
numbers following censoring: n = 355 for wild-type and n =
352 for daf-2(m41)).
Metabolite Analysis
We extracted metabolites following the method described by
Geier et al.26 Brieﬂy, the frozen pellets were extracted directly
into ice-cold 80% methanol by bead-beating using 1 mm
zirconia beads with a Precellys Dual (Cepheid, UK), and the
extracts were dried under reduced pressure. The dried extracts
were then resuspended in 0.65 mL of NMR buﬀer (0.1 M
phosphate pH 7.0 and 0.97 mM sodium trimethylsilyl-2H4-
propionate (TSP), in 100% 2H2O), centrifuged (10 min,
16 000g), and 0.6 mL of the supernatant transferred to a 5 mm
NMR tube. The TSP served as an internal frequency standard,
and the 2H2O both provided a ﬁeld frequency lock for the
spectrometer and helped reduce the signal from water. We
analyzed the samples by 1H NMR spectroscopy, using an
Avance II DRX800 spectrometer equipped with a 18.2 T triple-
resonance inverse cryoprobe with a proton resonance
frequency of 800 MHz. The samples were held at 300 K
during acquisition. We acquired 1D spectra essentially as
described by Beckonert et al.27 Brieﬂy, we used the ﬁrst line of a
NOESY experiment for water suppression, and 256 scans per
sample, with a recycle time of 5 s per scan. We processed the
data in NMR Suite (Chenomx, Edmonton, Canada) and
manually corrected each spectrum for phase and baseline. We
then ﬁtted 33 metabolites to every spectrum using the
proprietary software library; all metabolites were present except
for trehalose, which we added to the library. Probabilistic




Metabolic Diﬀerences Associated with Aging
To investigate how the C. elegans metabolome ages, we studied
the wild-type strain, N2, and a long-lived mutant, daf-2(m41).
DAF-2 encodes an insulin receptor that regulates life
expectancy via the FOXO transcription factor, DAF-16.7,29
We sampled populations of synchronized wild-type and daf-
2(m41) worms at seven ages: ﬁrst, as young adults2.5 days
after hatching for N2 and 3.5 for daf-2(m41), taking into
account the latter’s slower developmentand then at days 6, 8,
10, 13, 16, and 20 after hatching. Using proton NMR
spectroscopy, we identiﬁed 33 metabolites and estimated
their pool sizes (Table S1). An unsupervised analysis (principal
components) was diﬃcult to interpret, as both genotype- and
age-related diﬀerences were visible on the same axes
(Supporting Information, Figure S1). We therefore used a
supervised approach to help separate out the diﬀerent eﬀects:
orthogonal projections to latent structures (O-PLS) can be
used to model factors in a supervised fashion but has the
additional beneﬁt that an extra and eﬀectively unsupervised axis
(or axes) can be extracted.30 This demonstrates that the strains
are clearly metabolically distinct (the model is supervised with
respect to genotype, i.e., correlated component); in addition,
there is a strong eﬀect of age on metabolite proﬁles, such that
both strains map to an unsupervised “age” axis (orthogonal
component) once the eﬀects of genotype are allowed for
(Figure 1). We then went on to examine the behavior of
individual metabolites using linear models and found that 26 of
them showed clear age-speciﬁc responses, that is, linear changes
in pool size with age in either genotype (p < 0.05, Figure 2A);
15 of these metabolites had signiﬁcantly diﬀerent gradients
between the genotypes (p < 0.05).
Surveying our metabolites, we found that DAF-2 modiﬁed
their age-speciﬁc responses in one of three ways. We used these
responses to classify them. The ﬁrst (class A) consists of
metabolites that show a large change with age in wild-type
worms but no change or only a modest change in daf-2 worms
(Figure 2B,i,ii): putrescine, serine, and citrate increase with age
in wild-type worms and show little or no change in daf-2
worms. The second (class B: phosphocholine, leucine, valine,
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isoleucine, cystathionine, phenylalanine, histidine, glycerol)
consists of those that show little or no change in wild-type
worms but a large change in daf-2 worms (Figure 2B,iii,iv). All
but phosphocholine decrease with age in daf-2 worms. The
third class of metabolites (class C: trehalose, tyrosine) have
opposite responses in wild-type and daf-2 worms (Figure
2B,v,vi).
Predictive Modeling of Age
The results show that there were, indeed, clear age-related
eﬀects on metabolism (Figure 1). To see if these metabolic
diﬀerences were suﬃcient to predict the age of worms, we
carried out a partial least-squares (PLS) regression of
metabolite pool size on age separately for each genotype,
using all 33 metabolites. In each case, we were able to construct
robust models (Figure 3A,B). Thus, metabolite concentrations
alone are excellent predictors of the chronological age of a
population of worms. Metabolites that predict chronological
age in one genotype need not, however, do so in another. This
is shown by the loadings of the metabolites for the diﬀerent
PLS models: as might be expected, class A metabolites (e.g.,
putrescine) load most strongly on the wild-type model, while
class B metabolites (e.g., valine) load on the daf-2 model; class
C metabolites load on both (Figure 3C).
Can we predict the relative “metabolic age” of our genotypes,
that is, what results do the daf-2 data give when applied to the
wild-type model? If the metabolome is causally linked to aging
resistance, then daf-2 worms should be metabolically younger
than wild-type at some, or even all, chronological ages. To
examine this, we ﬁtted the daf-2(m41) metabolome data to the
wild-type model and vice versa (Figure 3A,B). We found that
both models show that daf-2 is metabolically younger than
wild-type for part of the adult life. However, the two models
disagree when daf-2(m41) acquires resistance to aging. The
wild-type model predicts that daf-2 worms only acquire their
relative youth in middle age, around 15 days p.h. The daf-2
model, on the other hand, predicts that the wild-type worms are
“metabolically older” than daf-2 worms in early life, but the two
strains then converge. These divergent predictions clearly stem
from the fact that diﬀerent metabolites contribute to each
model. Which, if either, is right?
daf-2(m41) Worms Become Aging-Resistant in Middle Age
To discriminate between these two models, which we can call
“early-” versus “late-life” aging resistance, we investigated the
age-speciﬁc mortality of these genotypes. The most commonly
used model of aging, the Gompertz aging function, assumes
that the age-speciﬁc mortality rate, μx, can be decomposed into
two components, an age-independent mortality rate, a, and an
exponentially increasing age-dependent mortality rate, b.
μ = ax bx( )
If mortality rate is plotted against age on a semilogarithmic
plot, this implies a linear relationship, in which x is age, the
intercept is a, and the slope b, the last of which is generally held
to represent the “rate of aging”.31 If worm aging is adequately
described by this function and if long-lived mutants do, indeed,
have increased resistance to aging, then they should have a b
lower than that in wild-type worms. However, studies in many
organisms, including C. elegans, have shown that the rate of
aging can vary over the course of life;31,32 thus the dynamics of
aging may be more complicated than allowed by a simple
Gompertz model.
Many longevity assays of daf-2 mutants have been carried
out, but few have attempted to estimate age-speciﬁc mortality
rates. To estimate b, we assayed the longevity in a large
population of worms and ﬁtted one- and two-stage Gompertz
models to the data; in the latter, maximum likelihood estimates
Figure 1. Metabolic eﬀect of aging visible for both strains. Orthogonal
PLS discriminant analysis of genotype, using log-transformed and
mean-centered data, with one correlated and one orthogonal
component; here, the analysis is supervised with respect to strain
(correlated component) but unsupervised with respect to age
(orthogonal component). Wild-type, blue; daf-2(m41), red. Circle
size corresponds to age. Model statistics: R2Y = 0.737, Q2Y = 0.668.
Figure 2. (A) Linear changes in metabolite pool size in wild-type and
daf-2 worms. Linear increases with age are shown in red; linear
decreases are in blue. Metabolites with pool sizes not signiﬁcantly
ﬁtting a linear model are shown in gray. *P < 0.05; **P < 0.01; ***P <
0.001; ****P < 0.0001. (B) Age responses in selected metabolites:
(i,ii) metabolites that show a large change with age in wild-type worms
but no change or only a modest change in daf-2 worms; (iii,iv)
metabolites that show little/no change in wild-type worms but a large
change in daf-2 worms; (v,vi) metabolites showing opposite responses
in wild-type and daf-2 worms. Pool sizes have been averaged, and unit
variance has been standardized. Wild type, blue; daf-2(m41), red.
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of the parameters and break point are given by segmented
linear regression.33 For wild-type, we found that a two-stage
model ﬁtted the data signiﬁcantly better than a one-stage model
(p = 0.0007, two-sided Davies test) with a break at 17.5 days
(95% conﬁdence intervals: 12.8−19.6 days) and a sharp (10-
fold) increase in the rate of aging after the break: bWT,1 = 0.019
(−0.043; 0.082) and bWT,2 = 0.186 (0.123; 0.249). By contrast,
we found that for daf-2(m41) a two-stage model was not
justiﬁed (p = 0.3, two-sided Davies test), so we ﬁtted a one-
stage Gompertz: bdaf‑2 = 0.110 (0.099; 0.121). The diﬀerence
between these slopes is signiﬁcant (bWT,1 vs bdaf‑2 = p = 0.0003;
bWT,2 vs bdaf‑2 = p = 0.0003, ANCOVA) and shows that after the
middle age break-point daf-2(m41) worms age about 40%
slower than wild-type worms, but that younger worms age
about 6-fold faster. Thus, it appears that the dynamics of aging
in wild-type and daf-2(m41) worms are very diﬀerent, and that
daf-2(m41)’s resistance to aging is acquired in middle age
(Figure 3D). This pattern of relative age-speciﬁc mortality is
precisely that predicted by the wild-type model but is very
diﬀerent from the daf-2 model. That, in turn, suggests that class
A metabolites predict biological age but that class B metabolites
do not.
■ DISCUSSION
We do not know the functional signiﬁcance of these metabolite
classes but speculate that, if there are metabolites that have a
causal role in contributing to increased longevity, they would
have patterns like class B or C metabolites; that is, they would
be signiﬁcantly altered in long-lived worm strains but not in
wild-type, or they would have opposite responses in long-lived
and wild-type strains. For example, in an earlier study, we
showed that the branched chain amino acids (BCAAs),
isoleucine, leucine, and valine, are elevated in young adult
daf-2 worms;23 here, we conﬁrm that result but also show that
they are class B metabolites in that they converge to wild-type
levels later on. Since BCAAs are among the few DAF-2-
Figure 3. (A) PLS model based on wild-type (blue circles) with daf-2(m41) data ﬁtted (red triangles). (B) PLS model based on daf-2(m41) (red
circles) with wild-type data ﬁtted (blue triangles). Gray lines show a perfect ﬁt (x = y). Both models show that daf-2 is “metabolically younger” than
wild-type at some point in its life but at diﬀerent time points. (C) Metabolite loadings on PLS models. Wild-type high-loading region in blue; daf-
2(m41) high-loading region in red; combined in purple. Amino acids are designated with standard three-letter codes; the remainder are citrate (Cit),
glycerol (Glr), O-phosphocholine (O-Pch), O-phosphoserine (O-Pss), putrescine (Put), succinate (Suc), sn-glycero-3-phosphocholine (GPC), and
trehalose (Tre). Class A metabolites, green; class B, orange; class C, purple; no response, or genotype-indistinguishable response, gray. (D) Age-
speciﬁc mortality of wild-type (blue) and daf-2(m41) (red). Lines represent Gompertz ﬁts; the rate of aging is their slope, b. The best ﬁt to the wild-
type pattern of mortality is a two-stage Gompertz with a break at 17.5 days posthatch; in daf-2(m41), no such break is required, with the result that in
early adulthood it ages faster and in late life slower than wild-type.
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regulated metabolites that require DAF-1623the classical
test8they are strong candidates for being causally involved in
resistance to aging. Indeed, dietary BCAAs increase the lifespan
of mice when ﬁrst introduced to their diet in middle age.34
BCAAs also increase wild-type C. elegans’ lifespan when
introduced as a dietary supplement from hatching, although
nearly all amino acids were reported to have similar eﬀects on
lifespan under speciﬁc growth conditions.35 We previously
found that trehalose was upregulated in some daf-2 mutants
when they were young adults but not m41; here, we ﬁnd that it
is a class C metabolite that decreases strongly after middle age
in N2 worms but increases in daf-2(m41), so that by day 20,
daf-2(m41) worms have about 3-fold as much trehalose as N2
(Figure S2). Again, this is consistent with lifespan-extending
eﬀects reported in the literature: trehalose increases lifespan in
C. elegans, and feeding N2 worms trehalose during early
adulthood does not increase lifespan but feeding them in
middle age does increase their lifespan.36 Trehalose addition
does not extend the lifespan of daf-2 worms,36 and as the daf-2-
related diﬀerence appears strongly only from middle age, it may
be that because daf-2 worms have high trehalose already, the
extra trehalose does not have an eﬀect.
It is important to note that our analysis of 33 metabolites is
based on linear models. If pool sizes change in a nonlinear way
with ageand it is likely that they dothen our analysis will
tend to underestimate the amount of regulation. Additionally, it
is not necessarily the case that the metabolite changes observed
in daf-2(m41) worms would occur in other daf-2 alleles or in
other long-lived mutants. Proﬁling the aging process in double
mutants would provide yet further information; for example,
daf-2;daf-16 is a classic example of an epistatic interaction
where the lifespan extension is reversed by the presence of the
second mutation.37 We have previously identiﬁed daf-16-
dependent metabolic changes as a subset of daf-2-caused
changes at a single time point.23 While we have shown that this
type of study is a potentially useful way to generate testable
hypotheses, clearly further experiments are required to
investigate the functional link between mortality rate and
metabolic proﬁle.
We have previously reported that the use of 5′-ﬂuorodeox-
yuridine (FUdR) may have a genotype-speciﬁc eﬀect on the
levels of some metabolites,38 but collecting the biomass of
worms required for this analysis would not have been possible
without the use of FUdR or similar intervention. Eight
metabolites previously found to have levels aﬀected by an
interaction between FUdR and genotype were included in this
study. Of these, betaine, lactate, and NAD do not increase or
decrease signiﬁcantly with age in either strain in this data set,
and despite a more pronounced change in the presence of
FUdR, levels of glycerol and tyrosine were found at levels in
daf-2 lower than those of N2 worms under both conditions.
However, we recognize that caution should be used when
interpreting data for the three remaining metabolites; glutamate
and glutamine levels were lower in daf-2 than in N2 without
FUdR, but this change was reversed when grown on FUdR-
containing medium, and diﬀerences in GPC levels between
strains only existed in the presence of FUdR.
This study highlights the importance of evaluating multiple
time points in wild-type/mutant comparisons; given the
diﬀerences in the metabolic changes that occur with age in
the two strains, reporting absolute diﬀerences between
genotypes at only one time point may not be suﬃcient to
characterize metabolic changes of interest. Previously, we used
NMR-based metabolomics to compare the metabolic eﬀects of
several longevity mutants, including daf-2(m41), but this was
only at a single time point.23 Pontoizeau et al.39 compared wild-
type worms with long-lived dietary restriction mutants at two
time points (also using FUdR to inhibit reproduction): young
adulthood and day 7 of adulthood, reporting similar changes in
pool sizes with age in wild-type worms for several metabolites
including alanine, phosphocholine, and GPC. The pool size
changes of some metabolites, including leucine and trehalose,
were also consistent across long-lived mutants in both studies.
Thus, we conclude that (1) worms commence aging in
middle age; and (2) metabolites that are strongly correlated
with aging in wild-type worms but not in this daf-2 mutant
(class A) or are divergently regulated (class C) can be used to
accurately predict this pattern of aging. It has long been known
that individuals with diﬀerent genotypes have diﬀerent life
expectancies. This is true of mutant worms, and it is true of
natural genetic variance in humans.40−42 In addition, experi-
ments on single genotypes have shown that it is possible to
predict longevity for individuals based on the expression levels
of speciﬁc genes.43 However, life expectancy is a very crude
measure of mortality. It provides no information on the pattern
of age-speciﬁc mortalityit just tells you that one genotype
lives longer or shorter than another. Indeed, a diﬀerence in life
expectancy need not be due to a diﬀerence in the rate of aging
at all, as opposed to a diﬀerence in the age-independent rate of
death. It is clear, however, that the ability to predict the age-
dependent rate of mortality and morbidity (which is highly
correlated with mortality) would be of extraordinary medical
and social value. Our results provide a ﬁrst step to showing that
diﬀerent genotypes have diﬀerent patterns of age-speciﬁc
mortality that can be predicted by metabolomic markers. We
expect that the combination of genetic and metabolomic data
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